These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9345312

  • 21. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
    Wang SJ.
    Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
    [Abstract] [Full Text] [Related]

  • 22. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells.
    Shigeri Y, Fujimoto M.
    Neurosci Lett; 1993 Jan 04; 149(1):19-22. PubMed ID: 8469373
    [Abstract] [Full Text] [Related]

  • 23. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells.
    Dickenson JM, Hill SJ.
    Eur J Pharmacol; 1996 Apr 29; 302(1-3):141-51. PubMed ID: 8791002
    [Abstract] [Full Text] [Related]

  • 24. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM, Alexander SP, Hill SJ.
    Br J Pharmacol; 1998 Oct 29; 125(3):570-6. PubMed ID: 9806342
    [Abstract] [Full Text] [Related]

  • 25. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J, Edvinsson L, Bryan RM.
    J Cereb Blood Flow Metab; 2001 Jan 29; 21(1):77-84. PubMed ID: 11149671
    [Abstract] [Full Text] [Related]

  • 26. Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.
    Heredia Mdel P, Delgado C, Pereira L, Perrier R, Richard S, Vassort G, Bénitah JP, Gómez AM.
    J Mol Cell Cardiol; 2005 Jan 29; 38(1):205-12. PubMed ID: 15623437
    [Abstract] [Full Text] [Related]

  • 27. Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization.
    Voisin T, Goumain M, Lorinet AM, Maoret JJ, Laburthe M.
    J Pharmacol Exp Ther; 2000 Feb 29; 292(2):638-46. PubMed ID: 10640301
    [Abstract] [Full Text] [Related]

  • 28. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y, Nishi N, Nakagawa S, Koyama T.
    J Pharmacol Exp Ther; 1999 Dec 29; 291(3):1250-6. PubMed ID: 10565849
    [Abstract] [Full Text] [Related]

  • 29. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
    Westfall TC, Naes L, Gardner A, Yang CL.
    J Cardiovasc Pharmacol; 2006 Jun 29; 47(6):723-8. PubMed ID: 16810071
    [Abstract] [Full Text] [Related]

  • 30. An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.
    Krsmanovic LZ, Mores N, Navarro CE, Arora KK, Catt KJ.
    Proc Natl Acad Sci U S A; 2003 Mar 04; 100(5):2969-74. PubMed ID: 12591945
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Two different signaling mechanisms involved in the excitation of rat sympathetic neurons by uridine nucleotides.
    Bofill-Cardona E, Vartian N, Nanoff C, Freissmuth M, Boehm S.
    Mol Pharmacol; 2000 Jun 04; 57(6):1165-72. PubMed ID: 10825387
    [Abstract] [Full Text] [Related]

  • 33. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
    Gardner A, Westfall TC, Macarthur H.
    J Pharmacol Exp Ther; 2005 Jun 04; 313(3):1109-17. PubMed ID: 15687374
    [Abstract] [Full Text] [Related]

  • 34. Neuropeptide-induced [Ca2+]i transients in cultured bovine trabecular cells.
    Ohuchi T, Tanihara H, Yoshimura N, Kuriyama S, Ito S, Honda Y.
    Invest Ophthalmol Vis Sci; 1992 Apr 04; 33(5):1676-84. PubMed ID: 1559768
    [Abstract] [Full Text] [Related]

  • 35. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V, Donoso MV, Brown N, Fanjul R, López C, Fournier A, Huidobro-Toro JP.
    J Pharmacol Exp Ther; 1999 Jun 04; 289(3):1313-22. PubMed ID: 10336522
    [Abstract] [Full Text] [Related]

  • 36. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z.
    Can J Physiol Pharmacol; 2003 Feb 04; 81(2):177-85. PubMed ID: 12710532
    [Abstract] [Full Text] [Related]

  • 37. Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells.
    Vanderheyden PM, Van Liefde I, DeBacker JP, Ebinger G, Vauquelin G.
    Regul Pept; 1998 Sep 25; 75-76():191-9. PubMed ID: 9802409
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tyrosine hydroxylase phosphorylation increases in response to ATP and neuropeptide Y co-stimulation of ERK2 phosphorylation.
    Luke TM, Hexum TD.
    Pharmacol Res; 2008 Jul 25; 58(1):52-7. PubMed ID: 18639636
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.